| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.2 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.025 | 0.9 |